Personal profile

Research Interests

Research Topics

Development, Membrane Biology, Metabolic Regulation, Protein Structure, RNA Biology, Signal Transduction

Disease Research Interests

Cancer, Metabolic Disorders/Diabetes, Trauma, Bleeding & Tissue Regeneration


B.S., Peking University, China (Biology)
Ph.D., Rice University (Biochemistry)
Postdoc., Harvard University


Professional Information

Signal Transduction in Mammalian Cell Growth and Differentiation

Our laboratory is interested in understanding signal transduction mechanisms that underlie fundamental cellular and developmental processes in mammals. We employ a wide range of experimental approaches including molecular biology, cell biology, biochemistry, single-molecule biophysics, and mouse genetics. Currently we are pursuing the following areas of investigation:

  • mTOR Signaling Network. The mammalian target of rapamycin (mTOR), a member of the phosphatidylinositol kinase-related Ser/Thr protein kinase family, assembles a signaling network that is a master regulator of cell growth, proliferation, differentiation, and metabolism. The mTOR network senses the availability of nutrients (amino acids, in particular), and integrates other types of environmental cues, including growth factors, cellular energy levels, and various types of stress. Rapamycin, an exquisitely specific inhibitor for mTOR, is a bacterial macrolide that has tremendous clinical values. Rapamycin and its analogs have been approved by the FDA for three types of clinical use – as an immunosuppressant to prevent graft rejection after transplantation, an anti-restenosis agent used in angioplasty stenting, and an anti-cancer drug. Furthermore, the anti-aging effects of rapamycin have been well established in many organisms including rodents. Our biochemical, biophysical, and biological investigations continue to uncover regulators, pathways, and regulatory mechanisms in the mTOR signaling network. These efforts will not only advance our understanding of cellular regulation, but also facilitate the future design and improvement of therapeutic strategies.

  • Skeletal Muscle Regeneration. The adult skeletal muscle has a tremendous capacity for repair and regeneration upon injury. Another major focus in our lab is to understand the signal transduction mechanisms governing skeletal muscle regeneration. Using mouse models for injury-induced muscle regeneration complemented with in vitro experimental systems of myoblast differentiation, we interrogate the molecular wiring that controls the highly coordinated cellular events leading to the formation of multi-nucleated myofibers. Our findings have revealed a central role of mTOR in assembling pathways that regulate various stages of myogenesis, distinct from those that control cell growth. In addition, we have dissected the mechanisms of regulation by myogenic microRNAs. Our current efforts are also focused on myocyte-secreted cytokines and their signaling that critically contribute to myogenic differentiation in vitro and muscle regeneration in vivo. Knowledge gained may lead to potential future therapeutic targets for boosting adult muscle regenerative capacity and for treating aging- or disease-related muscular atrophy and dystrophy.

  • Lipid-Protein Interactions. Some phospholipids in the cell membrane play important regulatory roles rather than serving structural purposes, and these signaling lipids interact with proteins to effect the regulation. Revealing the specificity of lipid-protein interactions is pivotal to the understanding of lipid signaling, and a critical need is experimental approaches that enable investigation of such interactions in physiologically relevant contexts. In collaboration with Taekjip Ha Laboratory (Johns Hopkins University) we have recently developed a single-molecule pulldown (SiMPull) assay to study the interaction between lipid vesicles and proteins of interest in crude cell lysates with high sensitivity and specificity. We have also adopted a microscale thermophoresis (MST) assay to rapidly assess lipid binding by proteins in cell lysates. Taking advantage of these new assays we are re-evaluating phosphoinositide binding by PH domain-containing proteins, the largest family of putative lipid binding proteins in the human genome. Our results to date have already revealed a striking lipid binding specificity not previously appreciated. Further investigation of such interactions will likely yield novel biological insights.

Honors & Awards

University Award for Excellence in Graduate Student Mentoring, University of Illinois, 2021
Faculty Excellence Award, School of Molecular and Cellular Biology, University of Illinois, 2011
University Scholar, University of Illinois, 2007
American Cancer Society Research Scholar, 2003 - 2007
NIH Shannon Award for New Investigators, 1998
Irvington Institute of Immunology Fellow, 1994 - 1997

Office Address

Dept. of Cell and Developmental Biology
University of Illinois
601 S. Goodwin Avenue
Urbana, IL 61801

Office Phone

(217) 265-0674


Fingerprint is based on mining the text of the expert's scholarly documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or